Fox Chase Cancer Center's Kimberly Clinton Becomes Certified IRB Professional
Fox Chase Cancer Center's Institutional Review Board (IRB) regulatory coordinator, Kimberly Clinton, CIP, of Fallsington, PA, has been designated a Certified IRB Professional by Public Responsibility in Medicine and Research (PRIM&R). The IRB is responsible for in-depth reviews of all clinical trials, reviewing and approving informed consent forms, questionnaires and any materials used to recruit participants to studies.
As an IRB regulatory coordinator, Kimberly is responsible for managing the continuing review of all open protocols, the processing of amendments, the terminations of protocols, the IRB approval of recruitment material, and coordinating special projects key to regulatory compliance. Certification for Institutional Review Board (IRB) professionals plays a crucial role in protecting subjects within the research system. The certification process evaluates and validates individuals knowledge of ethical principles, historical events, regulatory requirements, and operational and functional issues relating to IRBs and other human subjects protection programs.
The Council for the Certification of IRB Professionals (CCIP), an initiative of PRIM&R, supports the goal of promoting human subjects protection. CCIP promotes the highest standards in the conduct of human and animal research through its voluntary certification program for individuals working with institutional review boards and human research protection programs. As of May 2006, 791 individuals have earned their "CIP" designation.
PRIM&R is dedicated to creating, implementing, and advancing the highest ethical standards in the conduct of research. Since 1974, PRIM&R has served the full array of individuals and organizations involved in biomedical and social science/behavioral/educational research. Members of the PRIM&R community include professionals representing human and animal research protection programs, as well as researchers, institutional officials, government personnel, subject advocates, ethicists, policy makers, pharmaceutical and biotechnology leaders, and attorneys.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.